A company that makes a mapping system to help doctors see high-resolution, 3D images of irregular heart rhythms in real time has raised $100 million in venture investment and a $70... Read more »
Even as Uber, Lyft, and other high-profile initial public offerings underperformed out of the gate, the average share price of companies that have gone public in the US this year is... Read more »
Conatus Pharmaceuticals said Monday that it would cut its staff by 40 percent and consider a sale or merger after a drug it was testing as a treatment for an increasingly... Read more »
Editing human DNA has entered the public consciousness in a big way in recent years with its increasing use in laboratories—and, in recent news that shocked the scientific community, in... Read more »
There’s a speed dating game of sorts happening as pharmaceutical companies that have approved cancer immunotherapies are testing their medications in combination with experimental drugs in hopes of reaching more patients.... Read more »
Most of the genetic analysis done today is performed on machines made by Illumina, the DNA sequencing giant.
Now a former director from the company is leading a startup that has... Read more »
Oncternal Therapeutics has joined the growing ranks of San Diego biotechs to go public, but it didn’t go through an IPO to get there.
The San Diego-based company said Monday that... Read more »
We at Xconomy were thrilled to see such a great turnout at our first-ever awards gala in San Diego. About 250 people from the local life sciences community filled a ballroom... Read more »
Two executives at software company Tealium were recognized Thursday with a regional “Entrepreneur of the Year” award from EY for their leadership of the rapidly growing San Diego-based tech firm, which... Read more »
Three wildly different startups among those incubating at EvoNexus, a La Jolla, CA-based nonprofit organization that supports early-stage tech companies, earned top marks from the audience at a pitch contest this... Read more »
Two weeks after raising $40 million to push ahead with its drug development programs, Inhibrx submitted paperwork to the SEC revealing that it aims to raise money in the public market,... Read more »
The nominees and finalists for the first-ever Xconomy Awards San Diego were an impressive bunch, making it tough for our judges and the editors to pick the winners. There were multiple... Read more »
On the eve of the start of the seventh annual San Diego Startup Week, let’s learn more about the event—which is expected to draw thousands to its talks and gatherings—and take... Read more »
Inhibrx, developer of protein drugs targeting cancer and other diseases, has raised $40 million from the hedge fund Viking Global Investors as the biotech steers several programs through early-stage clinical trials.... Read more »
Yet another new biotech company has been founded in San Diego by serial entrepreneur Mike Grey and other alumni of rare disease startup Lumena Pharmaceuticals.
Reneo Pharmaceuticals, which has offices in... Read more »
Let’s catch up with the latest life sciences news in San Diego.
— Cybersecurity company MedCrypt, which makes software to protect medical devices, raised a $5.3 million Series A funding round.... Read more »
BioClarity, which sells plant-based skincare products to online shoppers, announced Wednesday that it has raised a $13 million investment round.
The San Diego-based company is part of Adigica Health, an e-commerce... Read more »
The finalists in the Big Idea category of the Xconomy Awards San Diego are pursuing ambitious goals in pursuit of better ways of improving health. Their approaches range, from a new... Read more »
San Diego has had plenty of businesses go public in recent years, but most have been life sciences companies.
Now software startup Tealium, which has about 215 employees at its San... Read more »
[Updated 11:30 a.m. 5/16. See below.] Success in life sciences is always a team effort. Often, those doing the heavy lifting do so behind the scenes, without much external... Read more »